The ITA reports that a sample collected during an out-of-competition testing mission on 18 June 2025 from Dayanch Omirov, a Kurash athlete from Turkmenistan, has returned an AAF¹ for the prohibited substances metandienone metabolite and meldonium.
Metandienone is prohibited under the 2025 WADA Prohibited List as S1.1 Anabolic Androgenic Steroids (AAS). It is prohibited at all times (in- and out-of-competition) and is a non-specified substance. Metandienone is a potent anabolic steroid which increases testosterone levels, causing muscle-mass growth, endurance and strength.
Meldonium is prohibited under the 2025 WADA Prohibited List as S4. Hormone and Metabolic Modulators. It is also prohibited at all times (in- and out-of-competition) and classified as a non-specified substance. Meldonium may enhance sports performance by improving endurance and recovery through increased oxygen uptake and energy metabolism.
The athlete has been informed of the case and has the right to request the analysis of the B-sample.
If the B-sample analysis is requested and confirms the result of the A-sample, the case will be considered as a confirmed anti-doping rule violation. If the B-sample analysis is not requested, the case will also go ahead as a confirmed anti-doping rule violation. The athlete will have the opportunity to present his explanations for the result.
Further, in accordance with the World Anti-Doping Code and Article 7.4.1 of the IKA Anti-Doping Rules, a mandatory provisional suspension has been imposed on the athlete. The athlete has the right to challenge the provisional suspension and ask for its lifting.
Pursuant to the IKA’s delegation of its anti-doping program to the ITA, the prosecution of the case is being handled entirely by the ITA. Given that the case is underway, there will be no further comments made.